The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
07:00 06-Apr-2018 ABA Final Results RNS +3.16% Up
07:00 06-Apr-2018 ABA Proposed Cancellation of Admission RNS +3.16% Up
07:00 27-Feb-2018 ABA Strategy update RNS +14.96% Up
10:00 21-Dec-2017 ABA Completion of Demerger RNS -
15:50 19-Dec-2017 ABA Confirmation of Capital Reductions RNS -

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address Weston House, Bradgate Park View, Chellaston, Derby, DE73 5UJ, United Kingdom
Company website http://www.oxfordpharma...
Market cap(in millions)* £ 17.48
Listing/Admission to trading 12 Feb 2010
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index -
FTSE sector Nonequity Investment Instruments
FTSE sub-sector Nonequity Investment Instruments
Country of share register GB
Segment ASQ1
MiFID Status -
Exchange market size 75,000
ISIN number GB00B3LXPB43

ABACO CAPITAL share news analysis (ABA)